论文信息 - A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521). - 字舞流文

A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521).

R. Hannan | J. Purdy | M. Amin | E. Horwitz | A. Raben | J. Michalski | W. Shipley | G. Rodrigues | S. Rosenthal | O. Sartor | N. Pervez | R. Paulus | Chen Hu | M. Garzotto | L. Souhami | M. Reaume | L. Gomella | Scott G. Williams | A. Balogh | S. Williams